LivaNova公共 LIVN 深 沪
交易中 09-16 15:06:01 美东时间
48.90
+0.370
+0.76%
华盛通- 最 高49.06
- 今 开48.62
- 成交量 17.04万股
- 最 低 48.34
- 昨 收 48.53
- 总市值 26.38亿
- 52周最高 64.475
- 市盈率 静 151.07
- 换手率 0.32%
- 52周最低 42.75
- 委 比 65.47%
- 总股本 5395.62万
- 历史最高 131.54
- 量 比 0.47
- 振 幅 1.48%
- 历史最低 23.58
- 每 手 1
- 风险率 4.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LivaNova Announces CHRO Hebbelinck’s Planned Departure and Benefits
LivaNova ( ($LIVN) ) has provided an announcement. LivaNova PLC has announced t...
09-10 21:28
LivaNova beats Q2 consensus, updates guidance
LivaNova PLC press release (NASDAQ:LIVN): Q2 Non-GAAP EPS of $0.93 beats by $0.15. Revenue of $318.6M (+8.4% Y/Y) beats by $13.36M. FY 2024 Guidance LivaNova now expects revenue for full-year 2024 to ...
07-31 18:05
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Baird analysts outlined stocks within medical technology where they see an upside during the second quarter’s earnings. Healthcare and med-tech has underperformed the broader market year-to-date, but ...
07-18 23:34
The top growth stocks, ranked by Seeking Alpha analyst ratings
Seeking Alpha analysts ranks the highest rated growth stocks, which are companies anticipated to growth a significant pace compared to the average growth for the market. The list is generated by Seeki...
07-13 01:02
Mizhuo's top picks in healthcare for July
Mizhuo picks Axsome Therapeutics (AXSM), Wave Life Sciences (WVE), Arcutis Biotherapeutics (ARQT), LivaNova (LIVN) and Humana (HUM) as July’s top picks. Mizhuo put out a list of its top stock picks fo...
07-04 01:34
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN
NEW YORK, June 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LivaNova PLC ("LivaNova" or the "Company") (NASDAQ: LIVN). Such investors are advised ...
06-25 05:48
LivaNova’s Annual Meeting Strengthens Shareholder Alignment
The latest announcement is out from LivaNova (LIVN). LivaNova PLC successfully ...
06-13 05:00
LivaNova: A Strong Buy Opportunity Amidst RECOVER Trial Developments
Analyst Anthony Petrone from Mizuho Securities maintained a Buy rating on LivaN...
06-12 15:55
LivaNova stock falls 11% on VNS Therapy study setback
Shares of LivaNova (NASDAQ:LIVN) fell 11% in late morning trading Thursday after the company reported that the unipolar patient cohort of its RECOVER study for its VNS Therapy product for treatment-re...
06-06 23:37
LivaNova Refocuses Structure, Integrates Circulatory Support
An announcement from LivaNova PLC (LIVN) is now available. In a strategic shift...
05-01 18:22
